Briefing note for OECD Health Data 2012: How Does the Netherlands Compare

Total health spending accounted for 12.0% of GDP in the Netherlands in 2010, the second highest among OECD countries and well above the OECD average of 9.5%.

Related Documents

• OECD Health Data 2012

Santé : le coût élevé du diabète

Quelque 83 millions de personnes sont atteintes de diabète dans l’ensemble des pays de l’OCDE. Compte tenu des tendances actuellement observées, ce sont près de 100 millions de personnes qui seront touchées par cette maladie à l’horizon 2030.

Long-Term Care

Description of the OECD's work on Long-Term Care.

Related Documents

• Analytical Health Projects
• Health Publications
• Long-Term Care for Older People: OECD study (2001-2004)

OECD Health Working Paper No. 55: Mortality Amenable to Health Care in 31 OECD Countries: Estimates and Methodological Issues

The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.

A System of Health Accounts: Implementation - Netherlands

Information on the status of implementation of OECD's A System of Health Accounts in the Netherlands.

A System of Health Accounts: Implementation in OECD countries

Information regarding the status of implementation of the System of Health Accounts in OECD countries, including SHA tables, working papers and reports on implementation.

Les tendances de l'incapacité parmi la population âgée: Analyse des évolutions dans 12 pays de l'OCDE et des implications futures (Document de travail sur la santé)

Alors que le nombre et la proportion de personnes âgées de 65 ans et plus vont continuer de s’accroître au cours des prochaines décennies, une amélioration de l’état fonctionnel des personnes âgées pourrait contribuer à ralentir l’augmentation de la demande.

Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

Related Documents

• Sectoral Case Studies in Innovation: Pharmaceutical biotechnology
• Pharmacogenetics: Opportunities and Challenges for Health Innovation